The neurodevelopmental nature of attention-deficit hyperactivity disorder in adults
- PMID: 33263274
- DOI: 10.1192/bjp.2020.200
The neurodevelopmental nature of attention-deficit hyperactivity disorder in adults
Abstract
Background: Population studies have suggested that most adults with attention-deficit hyperactivity disorder (ADHD) did not have the disorder in childhood, challenging the neurodevelopmental conceptualisation of ADHD. Arbitrary definitions of age at onset and lack of defined trajectories were accounted for the findings.
Aims: The objective of this study was to assess the proportion of individuals presenting with either a neurodevelopmental trajectory or late-onset disorder, and to assess risk factors associated with them.
Method: Data of 4676 individuals from the 1993 Pelotas birth cohort at 11, 15, 18 and 22 years of age were used. Polythetic and latent class mixed model analyses were performed to define ADHD trajectories from childhood to adulthood, and characterise the neurodevelopmental or late-onset courses. Regression models were applied to assess factors associated with different trajectories.
Results: Classical polythetic analyses showed that 67% of those with ADHD at 22 years of age had a neurodevelopmental course of the disorder. Latent class mixed model analysis indicated that 78% of adults with ADHD had a trajectory of persistent symptoms, more common in males. The remaining adults with ADHD had an ascending symptom trajectory that occurred after puberty, with late-onset ADHD associated with female gender and higher IQ.
Conclusions: Both polythetic and latent trajectories analyses provided empirical evidence supporting that the large majority of adults with ADHD had a neurodevelopmental disorder.
Keywords: ADHD; Late-onset; adult; neurodevelopmental; symptom trajectories.
Similar articles
-
Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.JAMA Psychiatry. 2016 Dec 1;73(12):1285-1292. doi: 10.1001/jamapsychiatry.2016.2817. JAMA Psychiatry. 2016. PMID: 27806167 Free PMC article.
-
Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome.JAMA Psychiatry. 2016 Jul 1;73(7):705-12. doi: 10.1001/jamapsychiatry.2016.0383. JAMA Psychiatry. 2016. PMID: 27192050
-
Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood.JAMA Psychiatry. 2016 Jul 1;73(7):713-20. doi: 10.1001/jamapsychiatry.2016.0465. JAMA Psychiatry. 2016. PMID: 27192174 Free PMC article.
-
Annual Research Review: Does late-onset attention-deficit/hyperactivity disorder exist?J Child Psychol Psychiatry. 2019 Apr;60(4):333-352. doi: 10.1111/jcpp.13020. Epub 2019 Mar 7. J Child Psychol Psychiatry. 2019. PMID: 30843223 Review.
-
[Can ADHD have an adulthood onset?].Encephale. 2019 Sep;45(4):357-362. doi: 10.1016/j.encep.2019.05.004. Epub 2019 Jun 27. Encephale. 2019. PMID: 31255245 Review. French.
Cited by
-
Default mode network connectivity and social dysfunction in children with Attention Deficit/Hyperactivity Disorder.Int J Clin Health Psychol. 2023 Oct-Dec;23(4):100393. doi: 10.1016/j.ijchp.2023.100393. Epub 2023 Jul 4. Int J Clin Health Psychol. 2023. PMID: 37829190 Free PMC article.
-
Personality Traits in Adolescents with ADHD: Insights into Dimension Evaluation and Clinical Implications Using the Personality Inventory for the DSM-5 Questionnaire.J Clin Med. 2025 Apr 28;14(9):3048. doi: 10.3390/jcm14093048. J Clin Med. 2025. PMID: 40364080 Free PMC article.
-
Toward Precision Medicine in ADHD.Front Behav Neurosci. 2022 Jul 6;16:900981. doi: 10.3389/fnbeh.2022.900981. eCollection 2022. Front Behav Neurosci. 2022. PMID: 35874653 Free PMC article. Review.
-
The SASOP/PsychMg child and adolescent attention-deficit/hyperactivity disorder guidelines.S Afr J Psychiatr. 2025 Feb 25;31:2357. doi: 10.4102/sajpsychiatry.v31i0.2357. eCollection 2025. S Afr J Psychiatr. 2025. PMID: 40061576 Free PMC article. No abstract available.
-
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder.Discov Ment Health. 2023 Jan 5;3(1):2. doi: 10.1007/s44192-022-00030-1. Discov Ment Health. 2023. PMID: 37861876 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical